Your browser doesn't support javascript.
loading
Glucose variability: a new risk factor for cardiovascular disease.
Belli, Martina; Bellia, Alfonso; Sergi, Domenico; Barone, Lucy; Lauro, Davide; Barillà, Francesco.
Affiliation
  • Belli M; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
  • Bellia A; Cardiovascular Imaging Unit, San Raffaele Scientific Institute, 20132, Milan, Italy.
  • Sergi D; Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
  • Barone L; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
  • Lauro D; Division of Cardiology, Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
  • Barillà F; Department of Systems Medicine, Tor Vergata University, 00133, Rome, Italy.
Acta Diabetol ; 60(10): 1291-1299, 2023 Oct.
Article in En | MEDLINE | ID: mdl-37341768
AIMS AND DATA SYNTHESIS: Glucose variability (GV) is increasingly considered an additional index of glycemic control. Growing evidence indicates that GV is associated with diabetic vascular complications, thus being a relevant point to address in diabetes management. GV can be measured using various parameters, but to date, a gold standard has not been identified. This underscores the need for further studies in this field also to identify the optimal treatment. CONCLUSIONS: We reviewed the definition of GV, the pathogenetic mechanisms of atherosclerosis, and its relationship with diabetic complications.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Angiopathies Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Acta Diabetol Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Diabetic Angiopathies Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Acta Diabetol Year: 2023 Document type: Article